{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:57Z","timestamp":1786980537199,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebral cavernous malformations (CCMs) are commonly diagnosed, with a low reported rate of haemorrhage on long-term follow-up. The identification of factors predictive of future haemorrhage risk would assist in guiding the management of patients with CCM. The aim of this study was to identify variables associated with haemorrhage, and calculate haemorrhage risk in CCM. We conducted a retrospective study of patients diagnosed with a CCM, managed at a specialist tertiary neuroscience centre (2007\u20132019). The primary outcome was symptomatic haemorrhage, and secondary outcomes were variables associated with increased risk of haemorrhage, using multivariable Cox regression analysis. Included were 545 patients, with 734 confirmed cavernomas. Median age at diagnosis was 47 (interquartile range [IQR] 35\u201360), with a median follow-up duration after diagnosis of 46 months (IQR 19\u201385). Of the patients, 15.0% had multiple lesions (\n                    <jats:italic>N<\/jats:italic>\n                    = 82\/545). Symptomatic presentation was observed in 52.5% of patients (\n                    <jats:italic>N<\/jats:italic>\n                    = 286\/545). The annual haemorrhage rate was 1.00% per lesion-year (25 events in 2512 lesion-years), and higher in those with symptoms at presentation (1.50% per lesion-year, 22 events vs 0.29%, 3 events,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001). The variables associated with symptomatic haemorrhage were\n                    <jats:underline>increased<\/jats:underline>\n                    size (hazard ratio [HR] 1.04, 95% confidence interval [CI] 1.01\u20131.07,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.004), eloquent location (HR 2.63, 95% CI 1.12\u20136.16,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.026), and symptomatic haemorrhage at presentation (HR 5.37, 95% CI 2.40\u201311.99,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001). This study demonstrated that CCMs have a low haemorrhage rate. Increased size, eloquent location, and haemorrhage at presentation appear to be predictive of a higher risk of haemorrhage, and could be used to stratify management protocols.\n                  <\/jats:p>","DOI":"10.1007\/s10143-023-01949-x","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T11:51:23Z","timestamp":1676029883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-3077","authenticated-orcid":false,"given":"Conor S.","family":"Gillespie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa E.","family":"Alnaham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-451X","authenticated-orcid":false,"given":"George E.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7703-0174","authenticated-orcid":false,"given":"Mohammad A.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel A.","family":"Taweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-043X","authenticated-orcid":false,"given":"Abdurrahman I.","family":"Islim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-7215","authenticated-orcid":false,"given":"Cathal John","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chavredakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"1949_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-444-63640-9.00023-0","volume":"143","author":"HE Goldstein","year":"2017","unstructured":"Goldstein HE, Solomon RA (2017) Epidemiology of cavernous malformations. Handb Clin Neurol 143:241\u2013247","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"1949_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00234-021-02852-2","volume":"64","author":"V Lohner","year":"2021","unstructured":"Lohner V et al (2021) Incidental findings on 3 T neuroimaging: cross-sectional observations from the population-based Rhineland Study. Neuroradiology 64(3):503\u2013512. https:\/\/doi.org\/10.1007\/s00234-021-02852-2","journal-title":"Neuroradiology"},{"issue":"9","key":"1949_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1212\/WNL.0b013e318248de9b","volume":"78","author":"KD Flemming","year":"2012","unstructured":"Flemming KD et al (2012) Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology 78(9):632\u2013636","journal-title":"Neurology"},{"key":"1949_CR4","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/j.wneu.2021.10.092","volume":"157","author":"Y Yang","year":"2021","unstructured":"Yang Y et al (2021) Natural history of brainstem cavernous malformations: on the variation in hemorrhage rates. World Neurosurg 157:e342\u2013e350","journal-title":"World Neurosurg"},{"key":"1949_CR5","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/j.wneu.2019.09.161","volume":"133","author":"KD Flemming","year":"2020","unstructured":"Flemming KD et al (2020) Predictors of initial presentation with hemorrhage in patients with cavernous malformations. World Neurosurg 133:e767\u2013e773","journal-title":"World Neurosurg"},{"key":"1949_CR6","doi-asserted-by":"publisher","first-page":"808314","DOI":"10.1155\/2015\/808314","volume":"2015","author":"N Mouchtouris","year":"2015","unstructured":"Mouchtouris N et al (2015) Management of cerebral cavernous malformations: from diagnosis to treatment. The Scientific World Journal 2015:808314","journal-title":"The Scientific World Journal"},{"issue":"2","key":"1949_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1474-4422(15)00340-3","volume":"15","author":"A Algra","year":"2016","unstructured":"Algra A, Rinkel GJE (2016) Prognosis of cerebral cavernomas: on to treatment decisions. The Lancet Neurology 15(2):129\u2013130","journal-title":"The Lancet Neurology"},{"key":"1949_CR8","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1016\/j.wneu.2019.12.035","volume":"135","author":"S Gomez-Paz","year":"2020","unstructured":"Gomez-Paz S et al (2020) Symptomatic hemorrhage from cerebral cavernous malformations: evidence from a cohort study. World Neurosurg 135:e477\u2013e487","journal-title":"World Neurosurg"},{"key":"1949_CR9","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/j.wneu.2019.07.222","volume":"131","author":"KN Kearns","year":"2019","unstructured":"Kearns KN et al (2019) Hemorrhage risk of untreated isolated cerebral cavernous malformations. World Neurosurg 131:e557\u2013e561","journal-title":"World Neurosurg"},{"issue":"12","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R et al (2008) Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 39(12):3222\u20133230","journal-title":"Stroke"},{"issue":"5","key":"1949_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3171\/2014.1.JNS131619","volume":"120","author":"SA Moore","year":"2014","unstructured":"Moore SA et al (2014) Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg 120(5):1188\u20131192","journal-title":"J Neurosurg"},{"issue":"5","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A et al (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80(5):665\u2013680","journal-title":"Neurosurgery"},{"issue":"3","key":"1949_CR13","first-page":"211","volume":"59","author":"H Choquet","year":"2015","unstructured":"Choquet H et al (2015) Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg 59(3):211\u2013220","journal-title":"J Neurosurg"},{"key":"1949_CR14","unstructured":"Morrison, L. and A. Akers, Cerebral cavernous malformation, Familial, in GeneReviews(\u00ae), M.P. Adam, et al., Editors. 1993, University of Washington, Seattle. Copyright \u00a9 1993-2021, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.: Seattle (WA)."},{"issue":"3","key":"1949_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3171\/2010.6.JNS091246","volume":"114","author":"EF Chang","year":"2011","unstructured":"Chang EF et al (2011) Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg 114(3):566\u2013573","journal-title":"J Neurosurg"},{"issue":"1","key":"1949_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2288-13-88","volume":"13","author":"X Xue","year":"2013","unstructured":"Xue X et al (2013) Testing the proportional hazards assumption in case-cohort analysis. BMC Med Res Methodol 13(1):88","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"1949_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1161\/STROKEAHA.117.017074","volume":"49","author":"CJ Stapleton","year":"2018","unstructured":"Stapleton CJ, Barker FG 2nd (2018) Cranial cavernous malformations: natural history and treatment. Stroke 49(4):1029\u20131035","journal-title":"Stroke"},{"issue":"2","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1474-4422(15)00303-8","volume":"15","author":"MA Horne","year":"2016","unstructured":"Horne MA et al (2016) Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 15(2):166\u2013173","journal-title":"Lancet Neurol"},{"issue":"12","key":"1949_CR19","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R et al (2008) Hemorrhage from cavernous malformations of the brain. Stroke 39(12):3222\u20133230","journal-title":"Stroke"},{"issue":"10","key":"1949_CR20","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1212\/WNL.0000000000005066","volume":"90","author":"S Kashefiolasl","year":"2018","unstructured":"Kashefiolasl S et al (2018) A benchmark approach to hemorrhage risk management of cavernous malformations. Neurology 90(10):e856\u2013e863","journal-title":"Neurology"},{"issue":"2","key":"1949_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3171\/2021.8.JNS211321","volume":"137","author":"A Orlev","year":"2021","unstructured":"Orlev A et al (2021) Neurological event prediction for patients with symptomatic cerebral cavernous malformation: the BLED2 score. J Neurosurg 137(2):344\u2013351. https:\/\/doi.org\/10.3171\/2021.8.JNS211321","journal-title":"J Neurosurg"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000341774","volume":"27","author":"D Kondziolka","year":"2013","unstructured":"Kondziolka D, Monaco EA 3rd, Lunsford LD (2013) Cavernous malformations and hemorrhage risk. Prog Neurol Surg 27:141\u2013146","journal-title":"Prog Neurol Surg"},{"issue":"2","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.1997.87.2.0190","volume":"87","author":"PJ Porter","year":"1997","unstructured":"Porter PJ et al (1997) Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 87(2):190\u2013197","journal-title":"J Neurosurg"},{"issue":"21","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/WNL.0000000000002701","volume":"86","author":"S Taslimi","year":"2016","unstructured":"Taslimi S et al (2016) Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology 86(21):1984\u20131991","journal-title":"Neurology"},{"issue":"10","key":"1949_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1474-4422(19)30231-5","volume":"18","author":"SM Zuurbier","year":"2019","unstructured":"Zuurbier SM et al (2019) Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. The Lancet Neurology 18(10):935\u2013941","journal-title":"The Lancet Neurology"},{"key":"1949_CR26","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/j.wneu.2022.03.101","volume":"163","author":"L Previch","year":"2022","unstructured":"Previch L et al (2022) The influence of select medications on prospective hemorrhage risk in patients with spinal or cerebral cavernous malformations. World Neurosurg 163:e678-683. https:\/\/doi.org\/10.1016\/j.wneu.2022.03.101","journal-title":"World Neurosurg"},{"issue":"2","key":"1949_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/13815","volume":"23","author":"SL-L Couteulx","year":"1999","unstructured":"Couteulx SL-L et al (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23(2):189\u2013193","journal-title":"Nat Genet"},{"issue":"2","key":"1949_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486292","volume":"9","author":"S Spiegler","year":"2018","unstructured":"Spiegler S et al (2018) Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol 9(2):60\u201369","journal-title":"Mol Syndromol"},{"issue":"4","key":"1949_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3171\/2016.3.JNS152419","volume":"126","author":"BA Gross","year":"2017","unstructured":"Gross BA, Du R (2017) Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. J Neurosurg 126(4):1079\u20131087","journal-title":"J Neurosurg"},{"key":"1949_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-319-02411-0_20","volume":"119","author":"A Pasqualin","year":"2014","unstructured":"Pasqualin A et al (2014) Results of surgery for cavernomas in critical supratentorial areas. Acta Neurochir Suppl 119:117\u2013123","journal-title":"Acta Neurochir Suppl"},{"issue":"1","key":"1949_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1227\/01.NEU.0000347009.32480.D8","volume":"65","author":"BA Gross","year":"2009","unstructured":"Gross BA et al (2009) Cavernous malformations of the basal ganglia and thalamus. Neurosurgery 65(1):7\u201318 discussion 18-9","journal-title":"Neurosurgery"},{"key":"1949_CR32","unstructured":"NIHR. Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. 2020 [cited 2022 27\/05\/2022]; Available from: https:\/\/www.journalslibrary.nihr.ac.uk\/programmes\/hta\/NIHR128694\/#\/."}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-01949-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:08:46Z","timestamp":1705925326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-01949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-01949-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"11 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital audit committee prior to commencement of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}